Number of Clinical Trials 2007

Explore the number of clinical trials conducted in various countries; critical for medical research and innovation.

99 data points••Global Coverage•Number of clinical trials | ClinicalTrials.gov via Our World in Data•

Newer data is available: Number of Clinical Trials by country 2024 →

Highest
United States
2,954
Lowest
Sierra Leone
1
Median country
4
Countries with data
99

Where does your country rank? Pick it to see its position.

Related Health statistics

More ↓

Interactive Map

Loading interactive map...

Complete Data Rankings

↑Top 10 Countries

  1. #1United States flagUnited States
  2. #2Germany flagGermany
  3. #3Canada flagCanada
  4. #4France flagFrance
  5. #5United Kingdom flagUnited Kingdom
  6. #6Denmark flagDenmark
  7. #7Italy flagItaly
  8. #8Japan flagJapan
  9. #9Netherlands flagNetherlands
  10. #10Brazil flagBrazil

Analysis: These countries represent the highest values in this dataset, showcasing significant scale and impact on global statistics.

↓Bottom 10 Countries

  1. #99Sierra Leone flagSierra Leone
  2. #98Senegal flagSenegal
  3. #97Rwanda flagRwanda
  4. #96Romania flagRomania
  5. #95Qatar flagQatar
  6. #94Puerto Rico flagPuerto Rico
  7. #93Northern Mariana Islands flagNorthern Mariana Islands
  8. #92Nepal flagNepal
  9. #91Morocco flagMorocco
  10. #90Madagascar flagMadagascar

Context: These countries or territories have the lowest values, often due to geographic size, administrative status, or specific characteristics.

Insights by country

1

Italy

In 2007, Italy ranked #7 globally with a total of 96 clinical trials. This figure is notable when compared to the global average, highlighting Italy's strong position in medical research within Europe. The country's robust healthcare system, combined with a rich history of pharmaceutical innovation and supportive regulatory frameworks, significantly contributes to its high number of clinical trials.

2

Bangladesh

In 2007, Bangladesh ranked #45 globally with a total of 5 clinical trials. This figure is relatively low compared to regional leaders, reflecting the country's developing research infrastructure. Factors contributing to this statistic include limited funding for medical research and a nascent regulatory environment for clinical studies, which can hinder the growth of clinical trial activities.

3

Hungary

In 2007, Hungary ranked #88 globally with a total of 1 clinical trial. This low figure reflects Hungary's position near the bottom of the global spectrum, especially when compared to leading countries in clinical research. Contributing factors include limited investment in research infrastructure and a smaller population base, which can hinder the recruitment of participants for clinical studies.

4

Malaysia

In 2007, Malaysia ranked #68 globally with a total of 2 clinical trials. This figure is notably lower than many of its regional neighbors, reflecting challenges in attracting international research investment. Factors such as limited funding for biomedical research and a relatively small population may have contributed to this low number, impacting the country's ability to participate in and host clinical studies.

5

Croatia

In 2007, Croatia ranked #62 globally with a total of 2 clinical trials. This figure is notably lower than many of its European neighbors, reflecting a limited capacity for clinical research at the time. Contributing factors include Croatia's relatively small population and emerging healthcare infrastructure, which may have hindered the development of a robust clinical trial environment.

6

Austria

In 2007, Austria ranked #22 globally with a total of 46 clinical trials. This figure is notably higher than the bottom-ranked countries, indicating a robust research environment. The country's strong healthcare system, combined with a well-developed infrastructure for clinical research and a high level of education among its workforce, contributes to its favorable position in clinical trial activity.

7

Colombia

In 2007, Colombia ranked #42 globally with a total of 6 clinical trials. This figure is notably lower than the leading countries in clinical research, reflecting the challenges faced by Colombia in attracting significant pharmaceutical investment compared to its regional peers. Factors such as a developing healthcare infrastructure and ongoing safety concerns have historically limited the country’s capacity to host a larger number of clinical trials.

8

Australia

In 2007, Australia ranked #15 globally with a total of 67 clinical trials. This number is significant compared to the global average, reflecting Australia's robust healthcare system and research capabilities. The country's strong emphasis on medical research, supported by government funding and a well-established pharmaceutical sector, drives its high ranking in clinical trials.

9

Portugal

In 2007, Portugal ranked #51 globally with a total of 4 clinical trials. This figure is notably lower than many of its European neighbors, reflecting a limited capacity for clinical research compared to countries like Germany, which leads in this area. Contributing factors include Portugal's smaller population and healthcare funding, which may restrict the scale and scope of clinical research initiatives.

10

Argentina

In 2007, Argentina ranked #30 globally with a total of 18 clinical trials. This figure is relatively low compared to top-ranked countries, highlighting the competitive landscape of clinical research. Factors contributing to this number include Argentina's robust healthcare system and its diverse population, which provides a wide range of potential participants for trials, though regulatory challenges may have limited growth in this sector.

Analysis & Context

In 2007, the United States led the world in the Number of Clinical Trials, with a staggering 2,954 trials conducted, while the global range spanned from 1 to 2,954. The global average stood at 55.10 trials, highlighting significant disparities in clinical research activities across different nations.

Global Leaders in Clinical Trials: Economic and Policy Influences

The dominance of the United States in clinical trials is largely attributed to its robust pharmaceutical industry, extensive healthcare infrastructure, and supportive regulatory environment. This has made the country a hub for medical innovation and research. Following the United States, Germany conducted 278 trials, and Canada carried out 246 trials. These countries benefit from strong economic support for research and development, as well as policies that incentivize clinical research.

European countries like France and the United Kingdom, with 157 and 154 trials respectively, also show significant activity. Their involvement is bolstered by well-established healthcare systems and collaborative networks that facilitate international research partnerships. The presence of numerous multinational pharmaceutical companies further enhances their capacity to conduct clinical trials.

Underrepresentation in Clinical Trials: Challenges and Barriers

At the opposite end of the spectrum, countries such as Sierra Leone, Senegal, and Rwanda each recorded just 1 clinical trial. This minimal activity can be attributed to limited healthcare infrastructure, insufficient funding for research, and regulatory hurdles that impede the establishment and execution of clinical trials.

Many lower-income countries face challenges including a lack of trained personnel and inadequate facilities, which hinder their ability to contribute to global clinical research. Additionally, the absence of strong regulatory frameworks can deter international pharmaceutical companies from investing in clinical trials in these regions.

Year-over-Year Changes: Notable Increases and Decreases

The analysis of year-over-year changes reveals significant trends in clinical trial activities. The United States experienced the largest increase, with 767 additional trials, marking a 35.1% growth. This surge is indicative of the country's continued investment in medical research and the expansion of its biopharmaceutical sector.

Other notable increases were seen in Germany and Canada, with 79 and 70 additional trials respectively, reflecting their strategic emphasis on becoming leaders in clinical research. In contrast, the Czech Republic and Colombia experienced decreases of 6 trials each, representing declines of 42.9% and 50.0% respectively. These reductions may result from shifting research priorities or financial constraints impacting the funding available for clinical trials.

Significance of Clinical Trials in Global Health

Clinical trials are pivotal for advancing medical knowledge and improving health outcomes worldwide. Countries with high numbers of trials, such as the United States and Germany, play a crucial role in developing new treatments and ensuring the safety and efficacy of medical interventions. These nations often set benchmarks for clinical research that others strive to emulate.

Conversely, the underrepresentation of clinical trials in low-income countries highlights a missed opportunity for these regions to benefit from advancements in medicine. Strengthening healthcare systems and establishing supportive policies could help bridge this gap, allowing for more equitable participation in global health research.

In conclusion, the Number of Clinical Trials conducted in 2007 underscores the varying capacities and priorities of countries in medical research. Addressing the disparities in clinical research activity is essential for fostering innovation and improving global health outcomes.

Frequently Asked Questions About Number of Clinical Trials in 2007

Which country conducted the most clinical trials in 2007?

The United States conducted the most clinical trials in 2007, with a total of 2,954 trials.

What was the average number of clinical trials per country in 2007?

The average number of clinical trials per country in 2007 was 55.1.

Which country had the fewest clinical trials in 2007?

Sierra Leone had the fewest clinical trials in 2007, with only 1 trial conducted.

What is the median number of clinical trials conducted by countries in 2007?

The median number of clinical trials conducted by countries in 2007 was 4.

Can you list the top three countries by the number of clinical trials in 2007?

The top three countries by the number of clinical trials in 2007 were the United States with 2,954 trials, Germany with 278 trials, and Canada with 246 trials.

How many countries conducted only one clinical trial in 2007?

Ten countries conducted only one clinical trial in 2007.

Data Source

Number of clinical trials | ClinicalTrials.gov via Our World in Data

Data produced by ClinicalTrials.gov, compiled and published by Our World in Data as "Number of clinical trials".

Visit Data Source

Cite this page

Geo Factbook. (n.d.). Number of Clinical Trials by Country, 2007. Retrieved November 16, 2026, from https://geofactbook.com/fact/number-of-clinical-trials/2007

The figures on this page come from Number of clinical trials | ClinicalTrials.gov via Our World in Data. For academic work, cite the original source as well.

›Embed this ranking on your site

Free to embed with attribution. Shows the top 10 countries and links back to the full ranking.

Preview

Historical Data by Year

Explore Number of Clinical Trials data across different years. Compare trends and see how statistics have changed over time.